2 Minute Medicine

No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Addition of palbociclib to adjuvant endocrine therapy does not improve survival in patients with HR⁺, HER2- breast cancer

byTeddy Guo

February 17, 2021

in StudyGraphics

Reading Time: 1 min read

#VisualAbstract: Positive Anti-Spike or Anti-Nucleocapsid Antibody Status is Associated with Reduced Incidence of SARS-CoV-2 Reinfection in Health Care Workers

Avacopan non-inferior to prednisone in the treatment of ANCA-associated vasculitis

RelatedReports

Variability in interpretation of breast biopsy slides associated with low verification of atypia and ductal carcinoma in situ

Chronic Disease

Statin use after but not before breast cancer diagnosis is associated with improved mortality in hormone receptor-positive early breast cancer

Weekly Rewinds

2 Minute Medicine Rewind June 8, 2026

3D mammography (tomosynthesis) enhances accuracy of breast cancer screening

Oncology

Sentinel lymph node biopsy may reduce the need for axillary dissection in cN1 breast cancer

Variability in interpretation of breast biopsy slides associated with low verification of atypia and ductal carcinoma in situ

Chronic Disease

Statins do not increase breast cancer risk in postmenopausal women

Next Post

Long-term use of rituximab associated with lower rates of AAV relapse

Avacopan non-inferior to prednisone in the treatment of ANCA-associated vasculitis

Quick Take: Risankizumab compared with adalimumab in patients with moderate-to-severe plaque psoriasis (IMMvent)

Bimekizumab is tolerable and efficacious for patients with moderate to severe plaque psoriasis

Combined MRI and NIH stroke scores may predict stroke prognosis

Maternal chronic conditions increase risk of cerebral palsy among offspring

No Result

View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.